Raptor Pharmaceutical Stock Price, News & Analysis (NASDAQ:RPTP)

$9.00 0.00 (0.00 %)
(As of 01/17/2018 03:19 PM ET)
Previous Close$9.00
Today's Range$8.95 - $9.05
52-Week Range$2.94 - $9.05
Volume753,200 shs
Average Volume1.42 million shs
Market Capitalization$767.76 million
P/E Ratio-10.47
Dividend YieldN/A
BetaN/A

About Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical logoRaptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryBiotechnology
SectorHealthcare
SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Debt-to-Equity Ratio1.33%
Current Ratio3.57%
Quick Ratio3.30%

Price-To-Earnings

Trailing P/E Ratio-10.4651162790698
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.86)
Net IncomeN/A
Net Margins-43.75%
Return on Equity-77.01%
Return on Assets-15.64%

Miscellaneous

Employees158
Outstanding Shares85,310,000

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

How were Raptor Pharmaceutical's earnings last quarter?

Raptor Pharmaceutical Corp (NASDAQ:RPTP) announced its earnings results on Thursday, August, 4th. The biotechnology company reported ($0.16) EPS for the quarter, topping the Zacks' consensus estimate of ($0.18) by $0.02. The biotechnology company earned $32.05 million during the quarter, compared to analysts' expectations of $28.52 million. Raptor Pharmaceutical had a negative return on equity of 77.01% and a negative net margin of 43.75%. The company's quarterly revenue was up 37.4% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.17) EPS. View Raptor Pharmaceutical's Earnings History.

Who are some of Raptor Pharmaceutical's key competitors?

How do I buy Raptor Pharmaceutical stock?

Shares of Raptor Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Raptor Pharmaceutical's stock price today?

One share of Raptor Pharmaceutical stock can currently be purchased for approximately $9.00.

How big of a company is Raptor Pharmaceutical?

Raptor Pharmaceutical has a market capitalization of $767.76 million. Raptor Pharmaceutical employs 158 workers across the globe.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (RPTP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  178 (Vote Underperform)
Total Votes:  357
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Raptor Pharmaceutical (NASDAQ:RPTP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AHold
Consensus Rating Score: N/AN/AN/A2.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$7.75
Price Target Upside: N/AN/AN/A13.70% downside

Raptor Pharmaceutical (NASDAQ:RPTP) Consensus Price Target History

Price Target History for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ:RPTP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/16/2016CowenDowngradeOutperform -> Market Perform$9.00N/AView Rating Details
9/12/2016WedbushReiterated RatingNeutral$9.00 -> $4.00N/AView Rating Details
9/8/2016FBR & CoReiterated RatingHoldN/AView Rating Details
8/8/2016CitigroupDowngradeBuy -> Neutral$6.00 -> $8.00N/AView Rating Details
4/12/2016Leerink SwannReiterated RatingOutperform$11.00N/AView Rating Details
4/11/2016OppenheimerReiterated RatingMarket PerformN/AView Rating Details
3/20/2016JMP SecuritiesDowngradeHoldN/AView Rating Details
(Data available from 1/17/2016 forward)

Earnings

Raptor Pharmaceutical (NASDAQ:RPTP) Earnings History and Estimates Chart

Earnings by Quarter for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ RPTP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.18)($0.16)$28.52 million$32.05 millionViewListenView Earnings Details
5/5/2016Q116($0.17)($0.17)$27.17 million$27.47 millionViewN/AView Earnings Details
2/25/2016Q415($0.19)($0.17)$26.08 million$24.67 millionViewListenView Earnings Details
11/5/2015Q315($0.18)($0.18)$24.25 million$25.80 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.12)$21.40 million$23.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.25)($0.24)$19.10 million$20.50 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.25)$20.12 million$17.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.18)($0.04)$18.90 million$23.80 millionViewN/AView Earnings Details
8/7/2014Q214($0.19)($0.15)$14.58 million$16.31 millionViewN/AView Earnings Details
5/8/2014Q413($0.17)($0.20)$11.81 million$12.10 millionViewN/AView Earnings Details
3/13/2014Q313($0.18)($0.19)$8.99 million$10.25 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.28)($0.29)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.30)($0.30)ViewN/AView Earnings Details
5/8/2013Q1 2013($0.26)($0.32)ViewN/AView Earnings Details
3/14/2013Q1 2013($0.27)($0.37)ViewN/AView Earnings Details
1/9/2013Q1 2013($0.23)($0.26)$0.25 millionViewN/AView Earnings Details
11/14/2012Q412($0.20)ViewN/AView Earnings Details
7/11/2012Q2 2012($0.18)($0.20)ViewN/AView Earnings Details
4/9/2012Q1 2012($0.18)($0.19)ViewN/AView Earnings Details
1/6/2012Q4 2011($0.23)($0.25)ViewN/AView Earnings Details
8/11/2009Q2 2009($0.65)ViewN/AView Earnings Details
5/1/2009Q1 2009($2.26)ViewN/AView Earnings Details
3/27/2009Q4 2008($3.21)ViewN/AView Earnings Details
11/12/2008Q3 2008($3.91)($5.82)ViewN/AView Earnings Details
8/8/2008Q2 2008($5.61)($8.04)ViewN/AView Earnings Details
5/13/2008Q1 2008($5.78)($4.20)ViewN/AView Earnings Details
3/26/2008Q4 2007($5.27)($8.81)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Raptor Pharmaceutical (NASDAQ:RPTP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Raptor Pharmaceutical (NASDAQ:RPTP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Raptor Pharmaceutical (NASDAQ RPTP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 54.88%
Insider Trades by Quarter for Raptor Pharmaceutical (NASDAQ:RPTP)
Insider Trades by Quarter for Raptor Pharmaceutical (NASDAQ:RPTP)

Raptor Pharmaceutical (NASDAQ RPTP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2015Suzanne Louise BruhnDirectorSell18,258$12.47$227,677.2648,437View SEC Filing  
9/2/2015Raymond AndersonDirectorSell4,916$12.51$61,499.166,695View SEC Filing  
8/31/2015Raymond AndersonDirectorSell8,084$12.52$101,211.686,695View SEC Filing  
7/1/2015Llew KeltnerDirectorSell50,000$16.05$802,500.00View SEC Filing  
6/18/2015Thomas E DaleyInsiderSell35,000$15.00$525,000.00View SEC Filing  
6/10/2015Suzanne Louise BruhnDirectorSell30,000$13.45$403,500.00View SEC Filing  
5/4/2015Richard L FranklinDirectorSell10,000$9.61$96,100.00View SEC Filing  
4/2/2015Richard L FranklinDirectorSell10,000$10.37$103,700.00View SEC Filing  
3/23/2015Christopher M StarrDirectorSell20,033$11.62$232,783.46View SEC Filing  
3/2/2015Richard L FranklinDirectorSell10,000$9.18$91,800.00View SEC Filing  
2/24/2015Christopher M StarrDirectorSell30,000$9.52$285,600.00View SEC Filing  
2/2/2015Richard L FranklinDirectorSell7,109$9.20$65,402.80View SEC Filing  
1/22/2015Christopher M StarrDirectorSell30,000$9.45$283,500.00View SEC Filing  
1/15/2015Christopher M StarrDirectorSell30,000$9.73$291,900.00View SEC Filing  
1/12/2015Raymond AndersonDirectorSell10,000$10.58$105,800.00View SEC Filing  
12/22/2014Christopher M StarrCEOSell30,000$9.00$270,000.00View SEC Filing  
12/15/2014Christopher M StarrCEOSell30,000$8.15$244,500.00View SEC Filing  
11/24/2014Christopher M StarrCEOSell30,000$9.97$299,100.00View SEC Filing  
10/22/2014Christopher M StarrCEOSell30,000$10.25$307,500.00View SEC Filing  
9/23/2014Christopher M StarrCEOSell30,000$10.21$306,300.00View SEC Filing  
9/16/2014Christopher M StarrCEOSell32,896$10.60$348,697.60View SEC Filing  
9/10/2014Raymond AndersonDirectorSell10,000$10.81$108,100.00View SEC Filing  
8/25/2014Erich SagerDirectorSell10,000$11.01$110,100.00View SEC Filing  
7/7/2014Llew KeltnerDirectorSell10,000$11.21$112,100.00View SEC Filing  
5/13/2014Georgia ErbezCFOBuy16,100$7.90$127,190.0016,100View SEC Filing  
4/7/2014Vijay SamantDirectorSell5,000$8.59$42,950.00View SEC Filing  
3/17/2014Christopher StarrCEOSell19,316$10.79$208,419.64699,370View SEC Filing  
1/13/2014Timothy WalbertDirectorSell5,520$15.06$83,131.20View SEC Filing  
1/9/2014Thomas DaleyInsiderSell15,000$14.17$212,550.0039,906View SEC Filing  
1/7/2014Llew KeltnerDirectorSell10,000$13.25$132,500.00View SEC Filing  
1/2/2014Richard FranklinDirectorSell10,715$13.12$140,580.80View SEC Filing  
12/9/2013Vijay SamantDirectorSell5,000$13.86$69,300.00View SEC Filing  
11/13/2013Timothy WalbertDirectorSell5,521$12.44$68,681.24View SEC Filing  
11/4/2013Richard FranklinDirectorSell10,715$14.88$159,439.20View SEC Filing  
10/15/2013Christopher M StarrCEOSell25,000$13.77$344,250.00View SEC Filing  
10/14/2013Suzanne Louise BruhnDirectorSell2,760$13.58$37,480.80View SEC Filing  
10/7/2013Vijay SamantDirectorSell5,000$14.76$73,800.00View SEC Filing  
9/16/2013Christopher StarrCEOSell25,000$14.21$355,250.00699,370View SEC Filing  
9/16/2013Erich SagerDirectorSell17,000$14.21$241,570.00130,727View SEC Filing  
9/13/2013Suzanne Louise BruhnDirectorSell2,760$14.07$38,833.20View SEC Filing  
9/9/2013Richard L FranklinDirectorSell10,715$14.24$152,581.60View SEC Filing  
9/9/2013Thomas E DaleyInsiderSell25,000$14.28$357,000.00View SEC Filing  
8/30/2013Georgia ErbezCFOSell7,400$13.42$99,308.00View SEC Filing  
12/28/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
11/26/2012Erich SagerDirectorSell11,279$5.00$56,395.00View SEC Filing  
9/12/2012Raymond AndersonDirectorSell2,000$5.50$11,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Raptor Pharmaceutical (NASDAQ RPTP) News Headlines

Source:

SEC Filings

Raptor Pharmaceutical (NASDAQ:RPTP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Raptor Pharmaceutical (NASDAQ:RPTP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Raptor Pharmaceutical (NASDAQ RPTP) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.